Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Gregory P Westcott"'
Publikováno v:
Cell Reports, Vol 36, Iss 2, Pp 109388- (2021)
Summary: Visceral adipose tissue (VAT) depots are associated with the adverse metabolic consequences of obesity, such as insulin resistance. The developmental origin of VAT depots and the identity and regulation of adipocyte progenitor cells have bee
Externí odkaz:
https://doaj.org/article/314695cbd1e7417aa236a5dba6b38d2a
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 3, Iss 2, Pp n/a-n/a (2020)
Abstract SGLT2 inhibitors (SGLT2i) are glucose‐lowering medications which increase the renal threshold for glucose reabsorption and promote glucosuria. Treatment with these agents raises serum ketone levels, and cases of diabetic ketoacidosis (DKA)
Externí odkaz:
https://doaj.org/article/731b0666b80b4e56a8e791f4f9b9f85d
Autor:
Marie E McDonnell, Rajesh Garg, Geetha Gopalakrishnan, Joanna Mitri, Ruth S Weinstock, Margaret Greenfield, Sai Katta, Jasmin Lebastchi, Nadine E Palermo, Ramya Radhakrishnan, Gregory P Westcott, Matthew Johnson, Donald C Simonson
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 108:718-725
ContextDiabetes or hyperglycemia at admission are established risk factors for adverse outcomes during hospitalization for COVID-19, but the impact of prior glycemic control is not clear.ObjectiveWe aimed to examine the associations between admission
Publikováno v:
Endocrine Practice. 28:1062-1068
Hypercalcemia is sometimes observed in patients with cirrhosis, but very little is known about the epidemiology in patients with hypercalcemia of chronic liver disease (HCLD) or how its presence may modulate the overall mortality risk. We assessed th
Autor:
Laura Johannes, Gregory P. Westcott
Publikováno v:
Clinical Diabetes.
Autor:
Gregory P. Westcott, MD, Abdollah Sadeghi-Nejad, MD, Juan Munoz-Pena, MD, Adam Blau, MD, Martin Goodman, MD, Richard D. Siegel, MD
Publikováno v:
AACE Clinical Case Reports, Vol 3, Iss 3, Pp e217-e224 (2017)
ABSTRACT: Objective: Congenital adrenal hyperplasia (CAH) can result in hormonal changes that influence gender identification and possibly the formation of adrenal myelolipomas in rare cases.Methods: A patient case is presented with associated litera
Externí odkaz:
https://doaj.org/article/644f1cdab22e4159ba8719fec4b52916
Autor:
MARIE E. MCDONNELL, DONALD C. SIMONSON, GEETHA GOPALAKRISHNAN, RAJESH GARG, JOANNA MITRI, RUTH S. WEINSTOCK, MARGARET GREENFIELD, NADINE E. PALERMO, RAMYA RADHAKRISHNAN, GREGORY P. WESTCOTT
Publikováno v:
Diabetes. 71
While diabetes and admission blood glucose (BG) are established risk factors for adverse outcomes during hospitalization for COVID-19, reports on the impact of prior glycemic control have been variable. We examined the relationship between acute and
Publikováno v:
Endocrine Practice. 27:8-14
Objective To determine the utility of measuring free T4 index (FT4I) in patients with low free T4 (FT4) levels using immunoassay and normal thyroid-stimulating hormone for the evaluation of secondary hypothyroidism. Methods We performed a retrospecti
Autor:
Ichitaro Abe, Yasuo Oguri, Anthony R.P. Verkerke, Lauar B. Monteiro, Carly M. Knuth, Christopher Auger, Yunping Qiu, Gregory P. Westcott, Saverio Cinti, Kosaku Shinoda, Marc G. Jeschke, Shingo Kajimura
Publikováno v:
Developmental cell. 57(23)
De novo beige adipocyte biogenesis involves the proliferation of progenitor cells in white adipose tissue (WAT); however, what regulates this process remains unclear. Here, we report that in mouse models but also in human tissues, WAT lipolysis-deriv
Autor:
Suraj J. Patel, Nan Liu, Sam Piaker, Anton Gulko, Maynara L. Andrade, Frankie D. Heyward, Tyler Sermersheim, Nufar Edinger, Harini Srinivasan, Margo P. Emont, Gregory P. Westcott, Jay Luther, Raymond T. Chung, Shuai Yan, Manju Kumari, Reeby Thomas, Yann Deleye, André Tchernof, Phillip J. White, Guido A. Baselli, Marica Meroni, Dario F. De Jesus, Rasheed Ahmad, Rohit N. Kulkarni, Luca Valenti, Linus Tsai, Evan D. Rosen
Publikováno v:
Sci Transl Med
Inflammation has profound but poorly understood effects on metabolism, especially in the context of obesity and nonalcoholic fatty liver disease (NAFLD). Here, we report that hepatic interferon regulatory factor 3 (IRF3) is a direct transcriptional r